Originally published by our sister publication Specialty Pharmacy Continuum
By Myles Starr
The Routine Assessment of Patient Index Data 3 (RAPID3) is the most common tool to determine physical functional, pain and global health in patients with rheumatoid arthritis. The assessment, based on patient-reported outcomes, saves time and helps identify patients in remission. However, RAPID3’s utility is limited because it cannot confirm that ongoing pain is caused by RA.
“One of the caveats